Protective Properties of Inactivated Virosomal Influenza Vaccine

М.К. Erofeeva , I.J. Nickonorov , V.L. Maksakova , M.A. Stukova , O.S. Konshina , E.A. Okhapkina , E.M. Voicehovskaya , S.A. Korovkin , S.J. Melnikhov , O.I. Kiselev
{"title":"Protective Properties of Inactivated Virosomal Influenza Vaccine","authors":"М.К. Erofeeva ,&nbsp;I.J. Nickonorov ,&nbsp;V.L. Maksakova ,&nbsp;M.A. Stukova ,&nbsp;O.S. Konshina ,&nbsp;E.A. Okhapkina ,&nbsp;E.M. Voicehovskaya ,&nbsp;S.A. Korovkin ,&nbsp;S.J. Melnikhov ,&nbsp;O.I. Kiselev","doi":"10.1016/j.provac.2014.07.005","DOIUrl":null,"url":null,"abstract":"<div><p>Currently, application of new technological solutions for the implementation of strategies for improving influenza vaccines are up to date and modern. In this study, we present data obtained in the evaluation of the safety and immunogenicity of the new Russian (national) split seasonal inactivated influenza vaccine ULTRIKS in comparison with a commercial vaccine VAXIGRIP in various age groups.</p></div>","PeriodicalId":89221,"journal":{"name":"Procedia in vaccinology","volume":"8 ","pages":"Pages 24-33"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.provac.2014.07.005","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Procedia in vaccinology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877282X1400006X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Currently, application of new technological solutions for the implementation of strategies for improving influenza vaccines are up to date and modern. In this study, we present data obtained in the evaluation of the safety and immunogenicity of the new Russian (national) split seasonal inactivated influenza vaccine ULTRIKS in comparison with a commercial vaccine VAXIGRIP in various age groups.

灭活病毒体流感疫苗的保护特性
目前,应用新技术解决方案来实施改进流感疫苗的战略是最新的和现代的。在这项研究中,我们介绍了俄罗斯(国家)新分离季节性灭活疫苗ULTRIKS与商业疫苗VAXIGRIP在不同年龄组中的安全性和免疫原性评估数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信